
Medacta Group SA
SIX:MOVE

Medacta Group SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
106.4
139.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Medacta Group SA hold over its rivals?
What risks and challenges
does Medacta Group SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Medacta Group SA.
Provide an overview of the primary business activities
of Medacta Group SA.
What unique competitive advantages
does Medacta Group SA hold over its rivals?
What risks and challenges
does Medacta Group SA face in the near future?
Has there been any significant insider trading activity
in Medacta Group SA recently?
Summarize the latest earnings call
of Medacta Group SA.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Medacta Group SA.
Provide P/S
for Medacta Group SA.
Provide P/E
for Medacta Group SA.
Provide P/OCF
for Medacta Group SA.
Provide P/FCFE
for Medacta Group SA.
Provide P/B
for Medacta Group SA.
Provide EV/S
for Medacta Group SA.
Provide EV/GP
for Medacta Group SA.
Provide EV/EBITDA
for Medacta Group SA.
Provide EV/EBIT
for Medacta Group SA.
Provide EV/OCF
for Medacta Group SA.
Provide EV/FCFF
for Medacta Group SA.
Provide EV/IC
for Medacta Group SA.
Show me price targets
for Medacta Group SA made by professional analysts.
What are the Revenue projections
for Medacta Group SA?
How accurate were the past Revenue estimates
for Medacta Group SA?
What are the Net Income projections
for Medacta Group SA?
How accurate were the past Net Income estimates
for Medacta Group SA?
What are the EPS projections
for Medacta Group SA?
How accurate were the past EPS estimates
for Medacta Group SA?
What are the EBIT projections
for Medacta Group SA?
How accurate were the past EBIT estimates
for Medacta Group SA?
Compare the revenue forecasts
for Medacta Group SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Medacta Group SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Medacta Group SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Medacta Group SA compared to its peers.
Compare the P/E ratios
of Medacta Group SA against its peers.
Discuss the investment returns and shareholder value creation
comparing Medacta Group SA with its peers.
Analyze the financial leverage
of Medacta Group SA compared to its main competitors.
Show all profitability ratios
for Medacta Group SA.
Provide ROE
for Medacta Group SA.
Provide ROA
for Medacta Group SA.
Provide ROIC
for Medacta Group SA.
Provide ROCE
for Medacta Group SA.
Provide Gross Margin
for Medacta Group SA.
Provide Operating Margin
for Medacta Group SA.
Provide Net Margin
for Medacta Group SA.
Provide FCF Margin
for Medacta Group SA.
Show all solvency ratios
for Medacta Group SA.
Provide D/E Ratio
for Medacta Group SA.
Provide D/A Ratio
for Medacta Group SA.
Provide Interest Coverage Ratio
for Medacta Group SA.
Provide Altman Z-Score Ratio
for Medacta Group SA.
Provide Quick Ratio
for Medacta Group SA.
Provide Current Ratio
for Medacta Group SA.
Provide Cash Ratio
for Medacta Group SA.
What is the historical Revenue growth
over the last 5 years for Medacta Group SA?
What is the historical Net Income growth
over the last 5 years for Medacta Group SA?
What is the current Free Cash Flow
of Medacta Group SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Medacta Group SA.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CH |
![]() |
Medacta Group SA
SIX:MOVE
|
2.4B CHF | 4.3 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
221.6B USD | 5.3 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.6B USD | 20.9 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
138.9B USD | 8.3 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
134.8B USD | 6 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
108.1B USD | 3.3 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
59.7B USD | 2.9 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
50.2B EUR | 2.2 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
41.1B USD | 7.6 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
259.1B CNY | 7 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
33B USD | 8.5 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
CH |
![]() |
Medacta Group SA
SIX:MOVE
|
Average P/S:
6.9
4.3
|
16%
|
0.3 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
5.3
|
7%
|
0.8 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
20.9
|
16%
|
1.3 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
8.3
|
12%
|
0.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
6
|
9%
|
0.7 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
3.3
|
5%
|
0.7 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
2.9
|
6%
|
0.5 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
2.2
|
7%
|
0.3 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
7.6
|
10%
|
0.8 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
7
|
14%
|
0.5 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
8.5
|
8%
|
1.1 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.